Frequency of SPEs* by category domains. by Emily E. Haroz (7839062)

Subjects:

S2 Fig - by Emily E. Haroz (7839062)

Subjects:

Examples of the matrixes of change objectives for the four target groups. by Mijkje Worm (18530902)

Subjects:

S1 Fig - by Emily E. Haroz (7839062)

Subjects:

S4 Fig - by Emily E. Haroz (7839062)

Subjects:

Project groups. by Mijkje Worm (18530902)

Subjects:

Data file from Delphi round 3. by Emily E. Haroz (7839062)

Subjects:

Data file from Delphi round 2. by Emily E. Haroz (7839062)

Subjects:

Elements classified as essential across 90% or more of the outcome domains. by Emily E. Haroz (7839062)

Subjects:

S3 Fig - by Emily E. Haroz (7839062)

Subjects:

Delphi process. by Emily E. Haroz (7839062)

Subjects:

Heatmap of SPEs and BCTs and their relative importance across outcome domains. by Emily E. Haroz (7839062)

Subjects:

Logic model of the problem. by Mijkje Worm (18530902)

Subjects:

Data file from Delphi round 1. by Emily E. Haroz (7839062)

Subjects:

Changeable determinants, theory- and evidence-based change methods, and practical applications for communication partners. by Mijkje Worm (18530902)

Subjects:

Flowchart of the literature selection process for papers on the effects of MPC on social and communication skills in children. by Mijkje Worm (18530902)

Subjects:

SPEs and behavioral change techniques classified by 50% or more respondents as essential by domain. by Emily E. Haroz (7839062)

Subjects:

Expanded version of the home visiting paradigm. by Emily E. Haroz (7839062)

Subjects:

Evaluation of preventable adverse drug reactions by implementation of the nationwide network of prospective drug utilization review program in Korea - Fig 1 by Jimin Lee (2552782)

Subjects:

Stakeholder interviewee categories, number of interviewees and their employers, and descriptions of stakeholders’ involvement in VMMC. by Adam Gilbertson (7817276)

Subjects: